Top

Current Obstetrics and Gynecology Reports

Published in:

01-09-2014 | Management of Uterine Fibroid (I Meinhold-Heerlein, Section Editor)

Surgical Treatment of Fibroids

Author: Ibrahim Alkatout

Published in: Current Obstetrics and Gynecology Reports | Issue 3/2014

Abstract

Uterine leiomyomas are the most common benign tumors of the female genital tract. Fibroids are associated with a variety of clinical problems, including bleeding disorders, bulk-related symptoms, and infertility. For women who wish to preserve their uterus, fibroids can be surgically removed by hysteroscopy, laparoscopy, or laparotomy. The only definitive solution, however, is hysterectomy. The choice of treatment must be made after carefully weighing alternative treatment methods, such as expectant management, medical treatment, and interventional radiology, and obtaining informed consent. The optimal treatment decision takes into account the interests and wishes of the patient as well as the practical feasibility in the clinical setup. Surgical skills and experience are an important factor, as surgical procedures on the uterus are not without risk, and can lead to severe complications. The decision to operate anticipates an improvement of the initial situation, and the appropriate surgical approach is of the utmost importance.

Buttram Jr VC, Reiter RC. Uterine leiomyomata: etiology, symptomatology, and management. Fertil Steril. 1981;36(4):433–45.PubMed

Lefebvre G, Vilos G, Allaire C, Jeffrey J, Arneja J, Birch C, et al. The management of uterine leiomyomas. J Obstet Gynaecol Can. 2003;25(5):396–418. quiz 9–22.PubMed

Alkatout I, Mundhenke C, Maass N, Schem C. Die Rolle der Angiogenese und seiner Inhibitoren in der Gynäkologie. Der Gynäkologe. 2012. (in press).

Peddada SD, Laughlin SK, Miner K, Guyon JP, Haneke K, Vahdat HL, et al. Growth of uterine leiomyomata among premenopausal black and white women. Proc Natl Acad Sci U S A. 2008;105(50):19887–92. doi:10.1073/pnas.0808188105.PubMedCentralPubMedCrossRef

Laughlin SK, Hartmann KE, Baird DD. Postpartum factors and natural fibroid regression. Am J Obstet Gynecol. 2011;204(6):496 e1–6. doi:10.1016/j.ajog.2011.02.018.CrossRef

Zaima A, Ash A. Fibroid in pregnancy: characteristics, complications, and management. Postgrad Med J. 2011;87(1034):819–28. doi:10.1136/postgradmedj-2011-130319.PubMedCrossRef

Marjoribanks J, Lethaby A, Farquhar C. Surgery versus medical therapy for heavy menstrual bleeding. Cochrane Database Syst Rev. 2006;2, CD003855. doi:10.1002/14651858.CD003855.pub2.PubMed

Al-Hendy A, Lee EJ, Wang HQ, Copland JA. Gene therapy of uterine leiomyomas: adenovirus-mediated expression of dominant negative estrogen receptor inhibits tumor growth in nude mice. Am J Obstet Gynecol. 2004;191(5):1621–31. doi:10.1016/j.ajog.2004.04.022.PubMedCrossRef

Edwards RD, Moss JG, Lumsden MA, Wu O, Murray LS, Twaddle S, et al. Uterine-artery embolization versus surgery for symptomatic uterine fibroids. N Engl J Med. 2007;356(4):360–70. doi:10.1056/NEJMoa062003.PubMedCrossRef

10.

van der Kooij SM, Bipat S, Hehenkamp WJ, Ankum WM, Reekers JA. Uterine artery embolization versus surgery in the treatment of symptomatic fibroids: a systematic review and metaanalysis. Am J Obstet Gynecol. 2011;205(4):17 e1–18. doi:10.1016/j.ajog.2011.03.016.

11.

Kim HS, Baik JH, Pham LD, Jacobs MA. MR-guided high-intensity focused ultrasound treatment for symptomatic uterine leiomyomata: long-term outcomes. Acad Radiol. 2011;18(8):970–6. doi:10.1016/j.acra.2011.03.008.PubMedCentralPubMedCrossRef

12.

Funaki K, Fukunishi H, Sawada K. Clinical outcomes of magnetic resonance-guided focused ultrasound surgery for uterine myomas: 24-month follow-up. Ultrasound Obstet Gynecol. 2009;34(5):584–9. doi:10.1002/uog.7455.PubMedCrossRef

13.

Gynaecologists RCoOa. Preventing entry-related gynaecological laparoscopic injuries. RCOG Green-top Guideline. 2008;No.49:1–10.

14.

Wallach EE, Vlahos NF. Uterine myomas: an overview of development, clinical features, and management. Obstet Gynecol. 2004;104(2):393–406. doi:10.1097/01.aog.0000136079.62513.39.PubMedCrossRef

15.

Kim MS, Uhm YK, Kim JY, Jee BC, Kim YB. Obstetric outcomes after uterine myomectomy: laparoscopic versus laparotomic approach. Obstet Gynecol Sci. 2013;56(6):375–81. doi:10.5468/ogs.2013.56.6.375.PubMedCentralPubMedCrossRef

16.

Lonnerfors C, Persson J. Pregnancy following robot-assisted laparoscopic myomectomy in women with deep intramural myomas. Acta Obstet Gynecol Scand. 2011;90(9):972–7. doi:10.1111/j.1600-0412.2011.01207.x.PubMedCrossRef

17.

Mettler L, Schollmeyer T, Tinelli A, Malvasi A, Alkatout I. Complications of uterine fibroids and their management, surgical management of fibroids, laparoscopy and hysteroscopy versus hysterectomy, haemorrhage, adhesions, and complications. Obstet Gynecol Int. 2012;2012:791248. doi:10.1155/2012/791248.PubMedCentralPubMed

18.

Di Spiezio Sardo A, Mazzon I, Bramante S, Bettocchi S, Bifulco G, Guida M, et al. Hysteroscopic myomectomy: a comprehensive review of surgical techniques. Hum Reprod Update. 2008;14(2):101–19. doi:10.1093/humupd/dmm041.PubMedCrossRef

19.

Emanuel MH, Hart A, Wamsteker K, Lammes F. An analysis of fluid loss during transcervical resection of submucous myomas. Fertil Steril. 1997;68(5):881–6.PubMedCrossRef

20.

Wamsteker K, Emanuel MH, de Kruif JH. Transcervical hysteroscopic resection of submucous fibroids for abnormal uterine bleeding: results regarding the degree of intramural extension. Obstet Gynecol. 1993;82(5):736–40.PubMed

21.

Hart R, Molnar BG, Magos A. Long term follow up of hysteroscopic myomectomy assessed by survival analysis. Br J Obstet Gynaecol. 1999;106(7):700–5.PubMedCrossRef

22.

Mettler L, Sammur W, Alkatout I, Schollmeyer T. Imaging in gynecologic surgery. Womens Health (Lond Engl). 2011;7(2):239–48. doi:10.2217/whe.11.6. quiz 49–50.CrossRef

23.

Varma R, Soneja H, Clark TJ, Gupta JK. Hysteroscopic myomectomy for menorrhagia using Versascope bipolar system: efficacy and prognostic factors at a minimum of one year follow up. Eur J Obstet Gynecol Reprod Biol. 2009;142(2):154–9. doi:10.1016/j.ejogrb.2008.10.006.PubMedCrossRef

24.

Loffer FD, Bradley LD, Brill AI, Brooks PG, Cooper JM. Hysteroscopic fluid monitoring guidelines. J Am Assoc Gynecol Laparosc. 2000;7(3):438.PubMedCrossRef

25.

Jansen FW, Vredevoogd CB, van Ulzen K, Hermans J, Trimbos JB, Trimbos-Kemper TC. Complications of hysteroscopy: a prospective, multicenter study. Obstet Gynecol. 2000;96(2):266–70.PubMedCrossRef

26.

Propst AM, Liberman RF, Harlow BL, Ginsburg ES. Complications of hysteroscopic surgery: predicting patients at risk. Obstet Gynecol. 2000;96(4):517–20.PubMedCrossRef

27.

Parker WH, Rodi IA. Patient selection for laparoscopic myomectomy. J Am Assoc Gynecol Laparosc. 1994;2(1):23–6.PubMedCrossRef

28.

Alkatout I, Bojahr B, Dittmann L, Warneke V, Mettler L, Jonat W, et al. Precarious preoperative diagnostics and hints for the laparoscopic excision of uterine adenomatoid tumors: two exemplary cases and literature review. Fertil Steril. 2010;95(3):1119 e5–8. doi:10.1016/j.fertnstert.2010.10.017.

29.

Dueholm M, Lundorf E, Hansen ES, Ledertoug S, Olesen F. Accuracy of magnetic resonance imaging and transvaginal ultrasonography in the diagnosis, mapping, and measurement of uterine myomas. Am J Obstet Gynecol. 2002;186(3):409–15.PubMedCrossRef

30.

Alkatout I, Honemeyer U, Strauss A, Tinelli A, Malvasi A, Jonat W, et al. Clinical diagnosis and treatment of ectopic pregnancy. Obstet Gynecol Surv. 2013;68(8):571–81. doi:10.1097/OGX.0b013e31829cdbeb.PubMedCrossRef

31.

Alkatout I, Schollmeyer T, Hawaldar NA, Sharma N, Mettler L. Principles and safety measures of electrosurgery in laparoscopy. JSLS. 2012;16(1):130–9. doi:10.4293/108680812X13291597716348.PubMedCentralPubMedCrossRef

32.

Alkatout I, Stuhlmann-Laeisz C, Mettler L, Jonat W, Schollmeyer T. Organ-preserving management of ovarian pregnancies by laparoscopic approach. Fertil Steril. 2011;95(8):2467–70 e1-2. doi:10.1016/j.fertnstert.2010.12.060.

33.

Kongnyuy EJ, Wiysonge CS. Interventions to reduce haemorrhage during myomectomy for fibroids. Cochrane Database Syst Rev. 2011;11, CD005355. doi:10.1002/14651858.CD005355.pub4.PubMed

34.

Zhao F, Jiao Y, Guo Z, Hou R, Wang M. Evaluation of loop ligation of larger myoma pseudocapsule combined with vasopressin on laparoscopic myomectomy. Fertil Steril. 2010;95(2):762–6. doi:10.1016/j.fertnstert.2010.08.059.CrossRef

35.

Tinelli A, Mettler L, Malvasi A, Hurst B, Catherino W, Mynbaev OA, et al. Impact of surgical approach on blood loss during intracapsular myomectomy. Minim Invasive Ther Allied Technol. 2013. doi:10.3109/13645706.2013.839951.PubMed

36.

Celik H, Sapmaz E. Use of a single preoperative dose of misoprostol is efficacious for patients who undergo abdominal myomectomy. Fertil Steril. 2003;79(5):1207–10.PubMedCrossRef

37.

Mettler L, Sammur W, Schollmeyer T, Alkatout I. Cross-linked sodium hyaluronate, an anti-adhesion barrier gel in gynaecological endoscopic surgery. Minim Invasive Ther Allied Technol. 2013;22(5):260–5. doi:10.3109/13645706.2012.751034.PubMedCrossRef

38.

Mettler L, Schollmeyer T, Alkatout I. Adhesions during and after surgical procedures, their prevention and impact on women's health. Womens Health (Lond Engl). 2012;8(5):495–8. doi:10.2217/whe.12.34.CrossRef

39.

Tulandi T, Murray C, Guralnick M. Adhesion formation and reproductive outcome after myomectomy and second-look laparoscopy. Obstet Gynecol. 1993;82(2):213–5.PubMed

40.

Tsuji S, Takahashi K, Imaoka I, Sugimura K, Miyazaki K, Noda Y. MRI evaluation of the uterine structure after myomectomy. Gynecol Obstet Invest. 2006;61(2):106–10. doi:10.1159/000089144.PubMedCrossRef

41.

D'Angelo E, Prat J. Uterine sarcomas: a review. Gynecol Oncol. 2009;116(1):131–9. doi:10.1016/j.ygyno.2009.09.023.PubMedCrossRef

42.

Mukhopadhaya N, De Silva C, Manyonda IT. Conventional myomectomy. Best Pract Res Clin Obstet Gynaecol. 2008;22(4):677–705. doi:10.1016/j.bpobgyn.2008.01.012.PubMedCrossRef

43.

Discepola F, Valenti DA, Reinhold C, Tulandi T. Analysis of arterial blood vessels surrounding the myoma: relevance to myomectomy. Obstet Gynecol. 2007;110(6):1301–3. doi:10.1097/01.AOG.0000290331.95709.26.PubMedCrossRef

44.

Pundir J, Pundir V, Walavalkar R, Omanwa K, Lancaster G, Kayani S. Robotic-assisted laparoscopic vs abdominal and laparoscopic myomectomy: systematic review and meta-analysis. J Minim Invasive Gynecol. 2013;20(3):335–45. doi:10.1016/j.jmig.2012.12.010.PubMedCrossRef

45.

Barakat EE, Bedaiwy MA, Zimberg S, Nutter B, Nosseir M, Falcone T. Robotic-assisted, laparoscopic, and abdominal myomectomy: a comparison of surgical outcomes. Obstet Gynecol. 2011;117(2 Pt 1):256–65. doi:10.1097/AOG.0b013e318207854f.PubMedCrossRef

46.

Mettler L, Clevin L, Ternamian A, Puntambekar S, Schollmeyer T, Alkatout I. The past, present and future of minimally invasive endoscopy in gynecology: a review and speculative outlook. Minim Invasive Ther Allied Technol. 2013;22(4):210–26. doi:10.3109/13645706.2013.823451.PubMedCrossRef

47.

Schollmeyer T, Mettler L, Jonat W, Alkatout I. Roboterchirurgie in der GynÃ¤kologie. Der GynÃ¤kologe. 2011;44(3):196–201. doi:10.1007/s00129-010-2709-z.

48.

George A, Eisenstein D, Wegienka G. Analysis of the impact of body mass index on the surgical outcomes after robot-assisted laparoscopic myomectomy. J Minim Invasive Gynecol. 2009;16(6):730–3. doi:10.1016/j.jmig.2009.07.014.PubMedCrossRef

49.

Falcone T, Parker WH. Surgical management of leiomyomas for fertility or uterine preservation. Obstet Gynecol. 2013;121(4):856–68. doi:10.1097/AOG.0b013e3182888478.PubMedCrossRef

50.

Garry R, Fountain J, Brown J, Manca A, Mason S, Sculpher M, et al. EVALUATE hysterectomy trial: a multicentre randomised trial comparing abdominal, vaginal and laparoscopic methods of hysterectomy. Health Technol Assess. 2004;8(26):1–154.PubMed

51.

Dietl J, Wischhusen J, Hausler SF. The post-reproductive Fallopian tube: better removed? Hum Reprod. 2011;26(11):2918–24. doi:10.1093/humrep/der274.PubMedCrossRef

52.

Worldwide AAMIG. AAGL position statement: robotic-assisted laparoscopic surgery in benign gynecology. J Minim Invasive Gynecol. 2013;20(1):2–9. doi:10.1016/j.jmig.2012.12.007.CrossRef

53.

Meeks GR, Harris RL. Surgical approach to hysterectomy: abdominal, laparoscopy-assisted, or vaginal. Clin Obstet Gynecol. 1997;40(4):886–94.PubMedCrossRef

54.

Mazdisnian F, Kurzel RB, Coe S, Bosuk M, Montz F. Vaginal hysterectomy by uterine morcellation: an efficient, non-morbid procedure. Obstet Gynecol. 1995;86(1):60–4. doi:10.1016/0029-7844(95)00086-7.PubMedCrossRef

55.

Jenkins TR. Laparoscopic supracervical hysterectomy. Am J Obstet Gynecol. 2004;191(6):1875–84. doi:10.1016/j.ajog.2004.06.096.PubMedCrossRef

56.

Berner E, Qvigstad E, Myrvold AK, Lieng M. Pelvic pain and patient satisfaction after laparoscopic supracervical hysterectomy: prospective trial. J Minim Invasive Gynecol. 2013. doi:10.1016/j.jmig.2013.10.011.

57.

Alkatout I, Mettler L, Beteta C, Hedderich J, Jonat W, Schollmeyer T, et al. Combined surgical and hormone therapy for endometriosis is the most effective treatment: prospective, randomized, controlled trial. J Minim Invasive Gynecol. 2013;20(4):473–81. doi:10.1016/j.jmig.2013.01.019.PubMedCrossRef

58.

Semm K. Hysterectomy via laparotomy or pelviscopy. A new CASH method without colpotomy. Geburtshilfe Frauenheilkd. 1991;51(12):996–1003. doi:10.1055/s-2008-1026252.PubMedCrossRef

Title: Surgical Treatment of Fibroids
Author: Ibrahim Alkatout
Publication date: 01-09-2014
Publisher: Springer US
Published in: Current Obstetrics and Gynecology Reports / Issue 3/2014
Electronic ISSN: 2161-3303
DOI: https://doi.org/10.1007/s13669-014-0090-y

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Surgical Treatment of Fibroids

Abstract

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 3/2014

Role and Risks of Morcellation Associated with Laparoscopic Management of Myomas

An Evidence-Based Approach to the Evaluation, Diagnostic Assessment, and Treatment of Fecal Incontinence in Women

Interstitial Cystitis/Painful Bladder Syndrome (IC/PBS): Is There Anything New under the Sun?

Erratum to: Update of Conservative Systemic Treatment of Uterine Fibroids

Recent Developments in the Non-surgical Management of Pelvic Organ Prolapse

Etiology, Pathogenesis, and Malignant Potential of Uterine Leiomyoma – A Review